The 'societal agreement' must be retained

"If you want that system to continue, if you want that innovation, you essentially need an agreement between payers, be it government or private, doctors and academia, the scientific community, and industry, to collaborate to make it happen," says Claus Zieler, senior vice president and head of commercial operations for Bayer Pharmaceuticals in Asia Pacific. …